Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Enrollment ongoing in phase I study of CodaVax-RSV vaccine

July 28, 2020

Suzhou Ark Biopharmaceutical presents new hepatitis B virus HBsAg secretion inhibitors

July 28, 2020

Macromolecular key to reversing multidrug resistance

July 28, 2020

Moderna announces phase III study initiation with mRNA-1273 for COVID-19

July 27, 2020

FDA approves IND to treat COVID-19 patients with stem cells

July 27, 2020

Exonbio launches SARS-CoV-2 monoclonal antibodies for research

July 24, 2020

Kaleido Biosciences initiates second study of KB-109 in outpatients with COVID-19

July 24, 2020

Topline phase III data for favipiravir in patients with COVID-19

July 24, 2020

Patient enrollment begins in Ampion COVID-19 program

July 24, 2020

Phase II/III study begins with mavrilimumab in severe COVID-19 pneumonia and hyperinflammation

July 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...